Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
Clinical trial NCT06958315 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06958315
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-16
- Primary completion
- 2027-05-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.